Since the outbreak of COVID-19, health care has become even more of a focus. China was already the second largest market for the healthcare sector and the largest consumer of cosmetics worldwide. With double-digit growth figures, the Chinese market continues to show enormous potential for development and continues to rely on high-quality goods from abroad. However, product certifications are a prerequisite for sales in China.
On March 26, 2020, Advantage Austria, together with Ms. Anna King, who has many years of experience in China certification as a consultant for CISEMA, informed about recent regulatory and institutional developments. The webinar took place in the context of the internationalisation campaign go-international.
In addition to details on the process, duration and costs of a certification as well as the choice of a suitable NMPA legal agent, the webinar focused on the restructuring of the authorities and introduced the responsible NMPA. Certification processes and the latest regulatory updates in the area of MedTech and cosmetics were then discussed. For medical devices, UDI (Unique Device Identification) barcodes, product risk classification, factory inspections abroad and clinical trials in China are among the most important topics. “Hot topics” for exporters of cosmetics include animal testing, new mandatory tests and the ban on microplastics.
Missed the webinar?
The video recording of the webinar can be viewed on YouTube. We hope that you will learn some valuable information.
